MRI-based multi-organ clocks for healthy aging and disease assessment Read more about MRI-based multi-organ clocks for healthy aging and disease assessment
Large-scale evaluation of proteomic and polygenic risk scores reveals complementary contributions to incident disease prediction Read more about Large-scale evaluation of proteomic and polygenic risk scores reveals complementary contributions to incident disease prediction
Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for osteomyelitis Read more about Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for osteomyelitis
PARK7 is a Key Regulator of Oxidative Stress - Related Breast Cancer Risk: A Multi-Omics Study Read more about PARK7 is a Key Regulator of Oxidative Stress - Related Breast Cancer Risk: A Multi-Omics Study
Genetic Association Between Sleep Traits and Vertigo Risk: A Two-Sample Bidirectional Mendelian Randomization Study Read more about Genetic Association Between Sleep Traits and Vertigo Risk: A Two-Sample Bidirectional Mendelian Randomization Study
Unveiling the interplay among skin microbiota, cytokines, and T2DM: an insightful Mendelian randomization study Read more about Unveiling the interplay among skin microbiota, cytokines, and T2DM: an insightful Mendelian randomization study
The genetics of low and high birthweight and their relationship with cardiometabolic disease Read more about The genetics of low and high birthweight and their relationship with cardiometabolic disease
Investigating potential drug targets for the treatment of glioblastoma: a Mendelian randomization study Read more about Investigating potential drug targets for the treatment of glioblastoma: a Mendelian randomization study
Assessing the genetic estimates of the association between plasma caffeine and cancer risk through Mendelian randomization Read more about Assessing the genetic estimates of the association between plasma caffeine and cancer risk through Mendelian randomization
Uncovering leading compounds for alzheimer’s disease treatment: mendelian randomization and virtual screening insights into plasma protein modulation Read more about Uncovering leading compounds for alzheimer’s disease treatment: mendelian randomization and virtual screening insights into plasma protein modulation